Global Protein Therapeutics Drugs Market Growth 2024-2030

Global Protein Therapeutics Drugs Market Growth 2024-2030

Protein Therapeutics Drugs are a type of medicine that are used to treat a variety of diseases such as cancer, metabolic, immunological, hematological, hormonal, genetic, infectious diseases, and others. These drugs have the potential to significantly improve human health. In principle, protein therapy is similar to gene therapy; which involves protein delivery in specific amounts to the body to facilitate precise functioning of different glands and other organs in the body

The global Protein Therapeutics Drugs market size is projected to grow from US$ 308160 million in 2024 to US$ 477510 million in 2030; it is expected to grow at a CAGR of 7.6% from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “Protein Therapeutics Drugs Industry Forecast” looks at past sales and reviews total world Protein Therapeutics Drugs sales in 2023, providing a comprehensive analysis by region and market sector of projected Protein Therapeutics Drugs sales for 2024 through 2030. With Protein Therapeutics Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Protein Therapeutics Drugs industry.

This Insight Report provides a comprehensive analysis of the global Protein Therapeutics Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Protein Therapeutics Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Protein Therapeutics Drugs market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Protein Therapeutics Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Protein Therapeutics Drugs.

Growth of the protein therapeutics market is majorly driven by rise in prevalence of chronic diseases and development of plasma-derived therapies. Increase in prevalence of various diseases such as cancer, metabolic disorders, genetic disorders, and immunological diseases are expected to propel demand for protein therapeutics. In addition, according to the World Health Organization (WHO), cancer is a leading cause of death worldwide, and cancer cases are expected to increase significantly in the future. Thus, rise in prevalence of cancer is anticipated to drive the protein therapeutics market.

This report presents a comprehensive overview, market shares, and growth opportunities of Protein Therapeutics Drugs market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Monoclonal Antibodies
Insulin
Fusion Protein
Erythropoietin
Interferon
Human Growth Hormone
Others

Segmentation by Application:
Cancer
Metabolic Disorders
Immunologic Disorders
Hematological Disorders
Hormonal Disorders
Genetic Disorders
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Johnson and Johnson
Pfizer Inc
F. Hoffmann La Roche Ltd
Novo Nordisk AS
Sanofi
Amgen Inc
Merck and Co., Inc
Abbott Laboratories
Baxter International Inc
Eli Lilly And Company
AbbVie
Novartis
Gilead Sciences
Bristol-Myers Squibb
Innovent
AstraZeneca
Hengrui Medicine
Takeda
Kanghong Pharma
Seagen
Sobi

Key Questions Addressed in this Report

What is the 10-year outlook for the global Protein Therapeutics Drugs market?

What factors are driving Protein Therapeutics Drugs market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Protein Therapeutics Drugs market opportunities vary by end market size?

How does Protein Therapeutics Drugs break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.